Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 3,000 shares for $75,000
ADPT•Insider share sale disclosure
- Adaptive Biotechnologies Chief Commercial Officer, MRD Susan Bobulsky sold 3,000 common shares on Aug. 10, 2026 at USD 25.
- Post-transaction holdings totaled 396,989 shares.
